Coldstream Capital Management Inc Pharming Group N.V. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Pharming Group N.V. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 106 shares of PHAR stock, worth $967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106Holding current value
$967% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PHAR
# of Institutions
5Shares Held
73.5KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY48KShares$438,2120.37% of portfolio
-
Cowen Prime Advisors LLC22.5KShares$205,0590.09% of portfolio
-
Morgan Stanley New York, NY2.9KShares$26,4770.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $596M
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...